Chinook Therapeutics to Present at the 2021 RBC Capital Markets Global Healthcare Conference
May 13 2021 - 3:05PM
Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical
company focused on the discovery, development and commercialization
of precision medicines for kidney diseases, today announced that
Chinook management is scheduled to participate in a virtual
fireside chat at the 2021 RBC Capital Markets Global Healthcare
Conference on Wednesday, May 19, 2021 at 10:55 am ET.
To access the live webcast and subsequent archived recording of
this and other company presentations, please visit the Investors
section of Chinook’s website. The archived webcast will remain
available for replay on Chinook’s website for 90 days.
About Chinook Therapeutics, Inc.Chinook
Therapeutics, Inc. is a clinical-stage biopharmaceutical company
developing precision medicines for kidney diseases. Chinook’s
product candidates are being investigated in rare, severe chronic
kidney disorders with opportunities for well-defined clinical
pathways. Chinook’s lead program is atrasentan, a phase 3
endothelin receptor antagonist for the treatment of IgA nephropathy
and other proteinuric glomerular diseases. BION-1301, an anti-APRIL
monoclonal antibody is being evaluated in a phase 1b trial for IgA
nephropathy. In addition, Chinook is advancing CHK-336, an oral
small molecule LDHA inhibitor for the treatment of primary
hyperoxaluria, as well as research programs for other rare, severe
chronic kidney diseases. Chinook is building its pipeline by
leveraging insights in kidney single cell RNA sequencing,
human-derived organoids and new translational models, to discover
and develop therapeutics with differentiating mechanisms of action
against key kidney disease pathways. To learn more, visit
www.chinooktx.com.
Contact:Noopur LiffickVice President, Investor
Relations & Corporate
Communicationsinvestors@chinooktx.commedia@chinooktx.com
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From Apr 2024 to May 2024
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From May 2023 to May 2024